New antibody drug aims to block Brain-Attacking autoantibodies
NCT ID NCT07093333
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This Phase 2a trial tests a drug called ART5803 in 30 adults with anti-NMDAR encephalitis or related psychiatric disease. The drug is a lab-made antibody designed to block harmful autoantibodies from attacking brain receptors. The study focuses on safety and tolerability, with early signs of effectiveness also being measured.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ART5803 (a lab-made antibody that blocks harmful autoantibodies from attacking brain receptors)
- What this could lead to
- If successful, this could point toward a targeted treatment for anti-NMDAR encephalitis and related psychiatric conditions, potentially reducing symptoms and improving quality of life.
- What could go wrong
- This is an early Phase 2a study with only 30 participants, so results may not apply to everyone. The drug's safety and effectiveness are still unproven, and side effects are possible.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANTI-N-METHYL-D-ASPARTATE RECEPTOR (NMDAR) ANTIBODY-ASSOCIATED PSYCHIATRIC DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Seoul National University Hospital
RECRUITINGSeoul, 03080, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a simple blood test unlock the secrets of brain autoimmune diseases?
- Can we predict who will relapse after brain inflammation?
- New study tracks pregnancy in women with neuroimmune diseases
- New study uses advanced scans to map brain inflammation over time
- Could Immune-Boosting drugs treat certain psychosis?
- Brain scan breakthrough: spotting hidden brain inflammation